Reversibility of acute intermediate phase bilirubin encephalopathy

Acta Paediatrica, International Journal of Paediatrics

Volumn 98, Issue 10, 2009, Pages 1689-1694

  Hansen, Thor Willy Ruud ^a,b,h   Nietsch, Lutz ^c   Norman, Elisabeth ^d   Bjerre, Jesper Vandborg ^e   Hascoet, Jean Michel ^f   Mreihil, Khalaf ^a,g   Ebbesen, Finn ^e  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c Alesund Hospital   (Norway)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

^e AARHUS UNIVERSITY HOSPITAL   (Denmark)

^f Maternite Regionale Universitaire   (France)

^g AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^h OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Bilirubin encephalopathy; Exchange transfusion; Intravenous immune globulin; Neonatal jaundice; Newborn; Phototherapy

Indexed keywords

ANTICONVULSIVE AGENT; DIAZEPAM; GALACTOSE; IMMUNOGLOBULIN; PHENOBARBITAL;

APNEA; ARTICLE; ARTIFICIAL VENTILATION; BRAIN; CASE STUDY; CLINICAL ARTICLE; DIET THERAPY; ELECTROENCEPHALOGRAM; EXCHANGE BLOOD TRANSFUSION; FEMALE; FOLLOW UP; GALACTOSEMIA; GLOBUS PALLIDUS; HUMAN; JAUNDICE; KERNICTERUS; LETHARGY; MALE; METABOLIC DISORDER; MUSCLE HYPOTONIA; NEUROIMAGING; NEWBORN; NEWBORN INTENSIVE CARE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTOTHERAPY; PRIORITY JOURNAL; SEIZURE;

ACUTE DISEASE; BILIRUBIN; COMBINED MODALITY THERAPY; EXCHANGE TRANSFUSION, WHOLE BLOOD; FEMALE; GLOBUS PALLIDUS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT, NEWBORN; JAUNDICE, NEONATAL; KERNICTERUS; MAGNETIC RESONANCE IMAGING; MALE; PHOTOTHERAPY;

EID: 69749102935     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2009.01409.x     Document Type: Article

References (31)

1. Ogunlesi TA, Dedeke IOF, Adekanmbi AF, Fetuga MB, Ogunfowora OB. The incidence and outcome of bilirubin encephalopathy in Nigeria: a bi-centre study. Nigerian J Med 2007 16 : 354 359.
2. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004 114 : 297 316.
3. Brown AK, Johnson L. Loss of concern about jaundice and the reemergence of kernicterus in full-term infants in the era of managed care. In : Fanaroff AA, Klaus MH, editors. The year book of neonatal and perinatal medicine. St. Louis, CA : Mosby-Year Book, 1996.
4. Bhutani VK, Johnson LH, Shapiro SM. Kernicterus in sick and preterm infants (1999-2002): a need for an effective preventive approach. Semin Perinatol 2004 28 : 319 325.
5. Ebbesen F. Recurrence of kernicterus in term and near-term infants in Denmark. Acta Paediatr 2000 89 : 1213 1217.
6. Bjerre JV, Ebbesen F. Incidence of kernicterus in newborn infants in Denmark. Ugeskr Laeger 2006 168 : 686 691.
7. Burke BL, Robbins JM, Bird TM, Hobbs CA, Nesmith C, Tilford JM. Trends in hospitalizations for neonatal jaundice and kernicterus in the United states 1988-2005. Pediatrics 2009 123 : 524 532.
8. Hansen TW, Cashore WJ, Oh W. Changes in piglet auditory brainstem response amplitudes without increases in serum or cerebrospinal fluid neuron-specific enolase. Pediatr Res 1992 32 : 524 529.
9. Hankø E, Hansen TW, Almaas R, Rootwelt T. Recovery after short-term bilirubin exposure in human NT2-N neurons. Brain Res 2006 1103 : 56 64.
10. Van Praagh R. Diagnosis of kernicterus in the neonatal period. Pediatrics 1961 28 : 870 876.
11. Hansen TW. Acute management of extreme neonatal jaundice - the potential benefits of intensified phototherapy and interruption of enterohepatic bilirubin circulation. Acta Paediatr 1997 86 : 843 846.
12. Newman TB, Liljestrand P, Jeremy RJ, Ferriero DM, Wu YW, Hudes ES, et al. Outcomes among newborns with total serum bilirubin levels of 25 mg per deciliter or more. New Engl J Med 2006 354 : 1889 1900.
13. Bjerre JV, Petersen JR, Ebbesen F. Surveillance of extreme hyperbilirubinaemia in Denmark. A method to identify the newborn infants. Acta Paediatr 2008 97 : 1030 1034.
14. Hankø E, Lindemann R, Hansen TW. Spectrum of outcome in infants with extreme neonatal jaundice. Acta Paediatr 2001 90 : 782 785.
15. Harris MC, Bernbaum JC, Polin JR, Zimmerman R, Polin RA. Developmental follow-up of breastfed term and near-term infants with marked hyperbilirubinemia. Pediatrics 2001 107 : 1075 1080.
16. Smitherman H, Stark AR, Bhutani VK. Early recognition of neonatal hyperbilirubinemia and its emergent management. Semin Fetal Neonat Med 2006 11 : 214 224.
17. Volpe JJ. Neurology of the newborn, 5th ed. Philadelphia, PA : Saunders Elsevier, 2008.
18. Maisels MJ, McDonagh AF. Phototherapy for neonatal jaundice. NEJM 2008 358 : 920 928.
19. McDonagh AF. Ex uno plures: the concealed complexity of bilirubin species in neonatal blood samples. Pediatrics 2006 118 : 1185 1187.
20. Huizing KMN, Røislien J, Hansen TWR. Intravenous immune globulin significantly reduces the need for exchange transfusions in infants with Rhesus and AB0 incompatibility. Acta Paediatr 2008 97 : 1362 1365.
21. Gourley GR, Li Z, Kreamer B, Kosorok MR. A controlled, randomized double-blind trial of prophylaxis against jaundice among breastfed newborns. Pediatrics 2005 116 : 385 389.
22. Schmid R, Marver HS, Hammaker L. Enhanced formation of rapidly labelled bilirubin by phenobarbital: hepatic microsomal cytochromes as a possible source. Biochem Biophys Res Comm 1966 24 : 319 328.
23. Wennberg RP, Ahlfors CE, Bhutani VK, Johnson LH, Shapiro SM. Toward understanding kernicterus: a challenge to improve the management of jaundiced newborns. Pediatrics 2006 117 : 474 485.
24. Ahlfors CE, Wennberg RP. Bilirubin-albumin binding and neonatal jaundice. Semin Perinatol 2004 28 : 334 339.
25. Maisels MJ. Jaundice. In : MacDonald MG, Mullett MD, Seshia MMK, editors. Avery's neonatology. Pathophysiology & management of the newborn, 6th ed. Philadelphia, PA : Lippincott Williams & Wilkins, 2005.
26. Lin Z, Fontaine J, Watchko JF. Coexpression of gene polymorphisms involved in bilirubin production and metabolism. Pediatrics 2008 122 : e156 62.
27. Huang MJ, Kua KE, Teng HC, Tang KS, Weng HW, Huang CS. Risk factors for severe hyperbilirubinemia in neonates. Pediatr Res 2004 56 : 682 689.
28. Watchko JF, Daood MJ, Mahmood B, Vats K, Hart C, Ahdab-Barmada M. P-glycoprotein and bilirubin disposition. J Perinatol 2001 21 (Suppl. 1 S43 7.
29. Falcao AS, Bellarosa C, Fernandes A, Brito MA, Silva RF, Tiribelli C, et al. Role of multidrug resistance-associated protein 1 expression in the in vitro susceptibility of rat nerve cell to unconjugated bilirubin. Neuroscience 2007 144 : 878 888.
30. Hansen TWR, Tommarello S, Allen JW. Oxidation of bilirubin by rat brain mitochondrial membranes - genetic variability. Biochem Mol Med 1997 62 : 128 131.
31. Strauss KA, Robinson DL, Vreman HJ, Puffenberger EG, Hart G, Morton DH. Management of hyperbilirubinemia and prevention of kernicterus in 20 patients with Crigler-Najjar disease. Eur J Pediatr 2006 165 : 306 319.